ArticleMikrochimica acta2025
Electrochemical detection of agomelatine using a high-performance FeZn LDH/graphene/polyaniline nanocomposite sensor for clinical and pharmaceutical analysis.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Novel Zeolite-Carbon Nanotube Composite Electrode for the Electrochemical Analysis of Agomelatine in Real Samples.Nanomaterials (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Therapeutic monitoring of agomelatine (AG), an antidepressant with significant pharmacokinetic variability, is hindered by the complexity and cost of conventional methods. This work presents a novel electrochemical sensor employing a ternary FeZn-layered double hydroxide (LDH)/graphene/polyaniline nanocomposite for sensitive AG detection in biological and pharmaceutical samples. The synergistic properties of the nanocomposite-combining catalytic activity, high conductivity, and electrochemical stability-were confirmed through XRD, FESEM-EDS, and XPS characterization. Electrochemical analysis showed a 65% reduction in charge transfer resistance and a 21-fold increase in electroactive surface area (0.576 cm
Indexed as
Identifiers
40817945What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.